Feds Consider Warnings on ADHD Drugs (AP)


<p><a href="http://us.rd.yahoo.com/dailynews/rss/health/*http://news.yahoo.com/s/ap/20060209/ap_on_he_me/attention_deficit"><img src="http://us.news3.yimg.com/us.i2.yimg.com/p/net/20060209/capt.cc5f115b1f5c966422165275e4b484fc?x=86&y=130&sig=VdLeuXLFKxdPY3hk5xzA2w--" align="left" height="130" width="86" alt="**FILE PHOTO** Sen. Charles Grassley, R-Iowa, speaks during a town hall meeting in Clarinda, Iowa, March 23, 2005. In a letter sent on Feb. 6, 2006, to the Food and Drug Administration, Grassley expressed concern that the agency 'is just now beginning to 'discuss approaches' for studying' risks associated with drugs used to treat attention deficit hyperactivity disorder. (AP Photo/Dave Weaver)" border="0" /></a>AP - Federal health advisers considered on Thursday whether warning labels might be needed on drugs for attention deficit hyperactivity disorder following the deaths of 25 people taking the increasingly popular medicines.</p><br clear=all>